The drug pricing debate in Washington has kicked into high gear, and it’s more contentious, convoluted, and misguided than ever. Who is on which team? Whose “turn” is next? And, more importantly, what is in the best interests of patients and taxpayers? These questions may sound rhetorical, but they are questions Congress should be asking. … Continue reading Securing an Affordable Healthcare Future for Patients